Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 242,984 shares of the company's stock, valued at approximately $9,634,000. Connor Clark & Lunn Investment Management Ltd. owned 0.26% of Acadia Healthcare at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Wellington Management Group LLP grew its holdings in shares of Acadia Healthcare by 12.2% during the third quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company's stock valued at $739,250,000 after buying an additional 1,266,384 shares during the last quarter. Holocene Advisors LP boosted its stake in Acadia Healthcare by 201.5% during the 3rd quarter. Holocene Advisors LP now owns 972,513 shares of the company's stock valued at $61,667,000 after purchasing an additional 649,997 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in Acadia Healthcare by 17.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock worth $198,258,000 after purchasing an additional 454,044 shares in the last quarter. Beach Point Capital Management LP purchased a new stake in shares of Acadia Healthcare in the fourth quarter worth approximately $14,097,000. Finally, Bank of Montreal Can lifted its holdings in shares of Acadia Healthcare by 2,456.1% in the third quarter. Bank of Montreal Can now owns 324,569 shares of the company's stock valued at $20,539,000 after purchasing an additional 311,871 shares in the last quarter.
Acadia Healthcare Stock Performance
Shares of Acadia Healthcare stock traded up $0.12 during trading hours on Wednesday, reaching $29.26. The company had a trading volume of 1,661,352 shares, compared to its average volume of 1,318,843. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. Acadia Healthcare Company, Inc. has a one year low of $27.61 and a one year high of $82.41. The firm has a market cap of $2.72 billion, a PE ratio of 9.59, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38. The business has a fifty day simple moving average of $39.52 and a 200 day simple moving average of $47.57.
Wall Street Analysts Forecast Growth
Several research firms have recently issued reports on ACHC. Royal Bank of Canada reduced their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research note on Monday, March 3rd. StockNews.com downgraded Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday, January 6th. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a "hold" rating to a "buy" rating and increased their price target for the company from $45.00 to $75.00 in a research report on Thursday, December 12th. Bank of America dropped their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research note on Friday, February 28th. Finally, TD Cowen dropped their price objective on Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating on the stock in a research note on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, Acadia Healthcare has a consensus rating of "Hold" and a consensus target price of $56.31.
Check Out Our Latest Analysis on ACHC
Acadia Healthcare Company Profile
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
